Passage Bio, Inc.

PASG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q May 16, 2022 10-Q
8-K May 16, 2022 8-K
4 May 5, 2022
4/A May 5, 2022
SC 13D/A May 5, 2022 AMENDMENT NO. 2
4 Apr 20, 2022 FORM 4 SUBMISSION
4 Apr 20, 2022 FORM 4 SUBMISSION
EFFECT Apr 14, 2022
DEFA14A Apr 14, 2022 DEFA14A
DEF 14A Apr 14, 2022 DEF 14A
3 Apr 8, 2022 FORM 3 SUBMISSION
4 Mar 23, 2022 FORM 4 SUBMISSION
8-K Mar 15, 2022 FORM 8-K
8-K Mar 11, 2022 FORM 8-K
8-K Mar 10, 2022 FORM 8-K
POS AM Mar 3, 2022 POS AM
S-8 Mar 3, 2022 S-8
POS AM Mar 3, 2022 POS AM
10-K Mar 3, 2022 10-K
8-K Mar 3, 2022 8-K
POSASR Mar 3, 2022 POSASR
4 Feb 14, 2022 PRIMARY DOCUMENT
4 Feb 14, 2022 PRIMARY DOCUMENT
4 Feb 14, 2022 PRIMARY DOCUMENT
4 Feb 14, 2022 PRIMARY DOCUMENT
← Newer Page 11 of 18 · 442 filings Older →